Mechanism of action of a flavin-containing monooxygenase

被引:147
作者
Eswaramoorthy, Subramaniam
Bonanno, Jeffrey B.
Burley, Stephen K.
Swaminathan, Subramanyam [1 ]
机构
[1] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA
[2] New York Struct Biol Ctr, New York, NY 10027 USA
[3] SGX Pharmaceut Inc, San Diego, CA 92121 USA
关键词
three-dimensional structure; xenobiotics; methimazole;
D O I
10.1073/pnas.0602398103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Elimination of nonnutritional and insoluble compounds is a critical task for any living organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble nucleophilic compounds to increase solubility and thereby increase excretion. Here we analyze the functional mechanism of FMO from Schizosaccharomyces pombe using the crystal structures of the wild type and protein-cofactor and protein-substrate complexes. The structure of the wild-type FMO revealed that the prosthetic group FAD is an integral part of the protein. FMO needs NADPH as a cofactor in addition to the prosthetic group for its catalytic activity. Structures of the protein-cofactor and protein-substrate complexes provide insights into mechanism of action. We propose that FMOs exist in the cell as a complex with a reduced form of the prosthetic group and NADPH cofactor, readying them to act on substrates. The 4 alpha-hydroperoxyflavin form of the prosthetic group represents a transient intermediate of the monooxygenation process. The oxygenated and reduced forms of the prosthetic group help stabilize interactions with cofactor and substrate alternately to permit continuous enzyme turnover.
引用
收藏
页码:9832 / 9837
页数:6
相关论文
共 30 条
[1]  
Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]
[2]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[3]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[4]   The implications of polymorphisms in mammalian flavin-containing monoloxygenases in drug discovery and development [J].
Cashman, JR .
DRUG DISCOVERY TODAY, 2004, 9 (13) :574-581
[5]   Human flavin-containing monooxygenase: Substrate specificity and role in drug metabolism [J].
Cashman, JR .
CURRENT DRUG METABOLISM, 2000, 1 (02) :181-191
[6]   A novel flavin-containing monooxygenase from Methylophaga sp strain SK1 and its indigo synthesis in Escherichia coli [J].
Choi, HS ;
Kim, JK ;
Cho, EH ;
Kim, YC ;
Kim, JI ;
Kim, SW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (04) :930-936
[7]   Phase combination and cross validation in iterated density-modification calculations [J].
Cowtan, KD ;
Main, P .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :43-48
[8]   Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods [J].
delaFortelle, E ;
Bricogne, G .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :472-494
[9]   SPECTROPHOTOMETRIC ASSAY OF THE FLAVIN-CONTAINING MONOOXYGENASE AND CHANGES IN ITS ACTIVITY IN FEMALE MOUSE-LIVER WITH NUTRITIONAL AND DIURNAL CONDITIONS [J].
DIXIT, A ;
ROCHE, TE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 233 (01) :50-63
[10]   Identification of a Baeyer-Villiger monooxygenase sequence motif [J].
Fraaije, MW ;
Kamerbeek, NM ;
van Berkel, WJH ;
Janssen, DB .
FEBS LETTERS, 2002, 518 (1-3) :43-47